Gastroenterology and Hepatology

Screening and surveillance; Molecular carcinogenesis in the gastrointestinal tract; Molecular genetics in gastroenterology and hepatology. Where are we and where are we going?; Current, potential and future prospects for imaging modalities; Pharmacology in hepatology and gastroenterology in the next Millennium; What is to be expected in acid related disorders: acid control and Helicobacter pylori; Can cholesterol gallstones be prevented?; Drug therapy of Crhn's disease in the year 1998; What should the clinician know about the cytochrome P450 system?; The esophagogastric junction; What causes transient lower esophagal sphincter relaxations?; The role of Helocobacter pylori in the gastroesophageal reflux disease; Inflammation and intestinal metaplasia of cardia andgastroesophageal junction; Proton pump inhibitors or laparoscopic antireflux surgery?; Progress in functional disorders; Functional disorders of the upper gastrointestinal tract. New concepts; Progress in functional disorder: functional lower intestinal disease.